₹ 2,023.40
-1.60 (-0.08%)
L
Lupin
₹ 2,023.40
Lupin EPS Summary (consolidated)
The latest quarterly EPS of Lupin as of Q2 Sep 2026 stands at ₹25.27. This is a 18.35% fall quarter on quarter and 21.91% fall same quarter last year. The forecasted EPS for Q2 Sep 2026 was ₹24.42. It beat the estimate by ₹0.85. For the FY2026 the EPS of Lupin stands at ₹116.75. This is a 62.27% growth compared with FY2025.
Lupin EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

